SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-030193
Filing Date
2024-03-04
Accepted
2024-03-04 06:03:09
Documents
18
Period of Report
2024-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247615d1_8k.htm   iXBRL 8-K 30585
2 EXHIBIT 99.1 tm247615d1_ex99-1.htm EX-99.1 12355
3 GRAPHIC image_009.jpg GRAPHIC 1978
4 GRAPHIC image_011.jpg GRAPHIC 1978
  Complete submission text file 0001104659-24-030193.txt   274815

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zura-20240304.xsd EX-101.SCH 3495
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240304_def.xml EX-101.DEF 26908
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240304_lab.xml EX-101.LAB 36975
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240304_pre.xml EX-101.PRE 25532
19 EXTRACTED XBRL INSTANCE DOCUMENT tm247615d1_8k_htm.xml XML 5501
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 24712735
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)